Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Effects of Hydroxyurea (HU) On Lymphocyte Subsets and the Immune Response to Pneumococcal, Measles, Mumps and Rubella Vaccination in the Pediatric Hydroxyurea Phase III Clinical Trial - BABY HUG - (ClinicalTrials.gov Identifier: NCT00006400)

Howard M. Lederman, MD, PhD, Margaret A. Connolly, PhD, Ram Kalpatthi, MD, Russell E. Ware, MD, PhD, Winfred C. Wang, MD, Lori Luchtman-Jones, MD, Myron Waclawiw, PhD, Jonathan C. Goldsmith, MD, James F. Casella, MD

Blood (2012) 120 (21): 243.

https://doi.org/10.1182/blood.V120.21.243.243

Published: 2012

Journal Articles

Fully Retargeted Oncolytic Measles Virus for Multiple Myeloma Therapy.

Horst D. Hummel, MD, Gaby Kuntz, Takafumi Nakamura, PhD, Axel Greiner, MD PhD, Stephen J. Russell, MD PhD, Hermann Einsele, MD, Max S. Topp, MD PhD

Blood (2006) 108 (11): 5474.

https://doi.org/10.1182/blood.V108.11.5474.5474

Published: 2006

Journal Articles

Development of Dendritic Cell Vaccine Against Measles for Patients Following Hematopoietic Cell Transplantation.

Tadashi Kumamoto, MD, PhD, Yuji Nashida, MD, Masahiro Hirayama, MD, PhD, Eiichi Azuma, MD, PhD, Yoshihiro Komada, MD, PhD

Blood (2005) 106 (11): 476.

https://doi.org/10.1182/blood.V106.11.476.476

Published: 2005

Journal Articles

Fully Retargeted Oncolytic Measles Virus Specific for the WUE-Ag Results in Specific Lysis of Multiple Myeloma Cells.

Horst-Dieter Hummel, Takafumi Nakamura, PhD, Gabriele Kuntz, Hermann Einsele, MD, Steve J. Russell, MD, Max S. Topp, MD

Blood (2005) 106 (11): 3053.

https://doi.org/10.1182/blood.V106.11.3053.3053

Published: 2005

Journal Articles

Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil

Clarisse M. Machado, Flávio B. Gonçalves, Cláudio S. Pannuti, Frederico L. Dulley, Vanda A. U. F. de Souza

Blood (2002) 99 (1): 83–87.

https://doi.org/10.1182/blood.V99.1.83

Published: 2002

NARROW

Effects of Hydroxyurea (HU) On Lymphocyte Subsets and the Immune Response to Pneumococcal, Measles, Mumps and Rubella Vaccination in the Pediatric Hydroxyurea Phase III Clinical Trial - BABY HUG - (ClinicalTrials.gov Identifier: NCT00006400)

Fully Retargeted Oncolytic Measles Virus for Multiple Myeloma Therapy.

Development of Dendritic Cell Vaccine Against Measles for Patients Following Hematopoietic Cell Transplantation.

Fully Retargeted Oncolytic Measles Virus Specific for the WUE-Ag Results in Specific Lysis of Multiple Myeloma Cells.

Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil

Email alerts

ASH Publications

American Society of Hematology

Effects of Hydroxyurea (HU) On Lymphocyte Subsets and the Immune Response to Pneumococcal, Measles, Mumps and Rubella Vaccination in the Pediatric Hydroxyurea Phase III Clinical Trial - BABY HUG - (ClinicalTrials.gov Identifier: NCT00006400)

Fully Retargeted Oncolytic Measles Virus for Multiple Myeloma Therapy.

Development of Dendritic Cell Vaccine Against Measles for Patients Following Hematopoietic Cell Transplantation.

Fully Retargeted Oncolytic Measles Virus Specific for the WUE-Ag Results in Specific Lysis of Multiple Myeloma Cells.

Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only